The BestQool Pro100 ranks 3rd for power output among tabletop red light therapy panels. Get 20% off during Black Friday 2025.
"It allows young adults with autism to maintain necessary supports during a critical transition period in their life." ...
NEW ORLEANS, LA—Among patients with atrial fibrillation (AF) undergoing PCI, 1 month of dual therapy with a direct oral ...
The HARMONi-A study is the first Phase III trial of an immunotherapy for EGFR-TKI-resistant, EGFR-mutated non-squamous NSCLC to show statistically significant and clinically meaningful improvements in ...
News-Medical.Net on MSN
Comparative study finds higher rates of adverse events with ticagrelor
One year of treatment with either of two strong blood-thinning medications—ticagrelor and prasugrel—by people with type 1 or ...
Three months after Rep. Ty Burns pleaded guilty to domestic abuse and assault, lawmakers are considering alternative PTSD ...
MedPage Today on MSN
Evolocumab Reduced First CV Events in Patients Without Prior MI or Stroke
NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac ...
Motherly on MSN
The quiet identity shift of becoming a working mom
Returning to work after baby is more than a schedule change. It is a shift in who you are, what you value and how you move through your day. Here is language for what you are feeling, plus a plan to ...
Scientists think urine from snakes and lizards could help them find new ways to prevent painful kidney stones and gout in ...
It’s the first study to show a PCSK9 inhibitor can reduce major events in high-risk patients who haven’t yet had one.
Exercises such as yoga, pilates, barre, walking, and more are great ways to build fitness and strength. However, they don't ...
Providers warn that allowing Medicaid reimbursement rate cuts to linger will have continued impact on patient care in North ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results